Ga68Ga-68

Ga-68是正电子发射断层扫描（PET）中广泛使用的放射性同位素，其半衰期为68分钟。这种同位素可用于标记不同的小分子和多肽，应用广泛。最常见的应用是前列腺癌显像（ (⁶⁸Ga-PSMA）和神经内分泌肿瘤显像（ (⁶⁸Ga-肽，如 DOTA-TATE、DOTA-TOC 和 DOTA-NOC）。

To produce Ga-68,
we recommend this production route:

Recommended
Cyclone:
Cyclone^® KIUBE
Download the brochure
要在回旋加速器上生产^{68</supGa，带正电荷的离子必须以 13 MeV 的能量到达靶。凭借独特的定制能量功能，Cyclone ^® KIUBE具有不同的出口能量，使您能够以高纯度达到最高的⁶⁸Ga产量。}

对于更少量的生产，Cyclone ^® KIUBE 还可以配备一个降能箔，使能量以13 MeV到达靶。

更多关于Cyclone^® KIUBE的信息

Target:
Nirta ^® 液体靶
富锌溶液在Nirta ⁶⁸Ga锥形靶中进行辐照。使用液体靶生产⁶⁸Ga是一种简单而经济有效的 GMP解决方案，与¹⁸F工艺类似。

更多关于Nirta^®液体靶的信息

Chemistry:
CASSY^® 紧凑自动扩展合成
以创新科技，满足您对放射性金属和示
踪剂的生产需求。

[⁶⁸Ga]Ga-tracers
[¹⁷⁷Lu]Lu-tracers
[⁶⁴Cu]Cu-tracers
[⁸⁹Zr]Zr-tracers

CASSY^®

专利EP15170854下的工艺
Recommended
Cyclone:
Cyclone^® KIUBE
Download the brochure
要在回旋加速器上生产⁶⁸Ga，带正电荷的离子必须以 13 MeV 的能量到达靶。凭借独特的定制能量功能，Cyclone ^® KIUBE具有不同的出口能量，使您能够以高纯度达到最高的⁶⁸Ga产量。

对于更少量的生产，Cyclone ^® KIUBE 还可以配备一个降能箔，使能量以13 MeV到达靶。

更多关于Cyclone^® KIUBE的信息

Target:
固体靶
⁶⁸Ga也可以使用固体靶获得。

更多关于固体靶的信息

Chemistry:
NEPTIS^® LC
治疗用放射性药物模块化平台

[¹⁸F]FDG
[⁶⁸Ga]Ga-tracers
[¹³¹I]I-tracers
[¹⁷⁷Lu]Lu-tracers
[⁸⁹Zr]Zr-tracers
[⁹⁰Y]Y-tracers
[²²⁵Ac]Ac-tracers

更多关于NEPTIS^® LC的信息
Alternative
Cyclone:
Cyclone^® IKON
Download the brochure
也可以使用Cyclone^® IKON 以 13 MeV的能量生产⁶⁸Ga。

更多关于Cyclone^® IKON的信息

Target:
固体靶
⁶⁸Ga也可以使用固体靶获得。IBA只提供辐照站设备。

更多关于固体靶的信息

Chemistry:
NEPTIS^® Perform
NEPTIS^® Perform
[¹⁸F]FDG
[¹⁸F]NaF
[¹⁸F]FLT
[¹⁸F]FMISO
[¹⁸F]FCH
[¹⁸F]FET
[¹⁸F]FES
[¹⁸F]F-L-DOPA
[¹⁸F]FHBG
[¹⁸F]PSMA1007
[⁶⁸Ga]Ga-tracers
[¹⁷⁷Lu]Lu-tracers

更多关于NEPTIS^® Perform
Alternative
Target:
⁶⁸Ge发生器
Cyclone^® 30 生产的⁶⁸Ge用于制造⁶⁸Ge/⁶⁸Ga发生器。⁶⁸Ge 是一种半衰期较长的同位素（270.95 天），其发生器可以运往世界各地。

更多关于 Cyclone^® 30 XP 的信息

Chemistry:
NEPTIS^® xSeed ^TM
NEPTIS^® xSeed^TM

更多关于NEPTIS^® xSeed^TM

Scientific publications

See more publications

Ga68Ga-68

To produce Ga-68,
we recommend this production route:

Cyclone:

Target:

Chemistry:

Cyclone:

Target:

Chemistry:

Cyclone:

Target:

Chemistry:

Target:

Chemistry:

Scientific publications

Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population

Automated synthesis of therapeutic activities of 177Lu and 131I radiopharmaceuticals and ⁶⁸Ga PET agents in a hospital radiopharmacy.

Automated [⁶⁸Ga]DOTA-NOC Production Using a Commercial Synthesizer

Simplified Automation of the GMP production of 68Ga-labelled peptides

Fully automated synthesis of 68Ga-labelled peptides using the IBA Synthera^® and Synthera^® Extension modules

Combining commercial production of multi-products in a GMP environment with Clinical & R&D activities

GMP Production of Gallium-68 from a Cyclotron Using Liquid Targets: Regulatory Aspects

Automated Purification of Radiometals Produced by Liquid Targets

Combining multi-product commercial production in a GMP environment with Clinical & R&D activities

Cyclotron production of Ga‐68 for human use from liquid targets: From theory to practice

GMP Production of Gallium-68 from a Cyclotron Using Liquid Targets: Regulatory Aspects

Production of copper-64 and gallium-68 with a medical cyclotron using liquid targets

Fast and cost-effective cyclotron production of 61Cu using a natZn liquid target: an opportunity for radiopharmaceutical production and R&D

Optimized non-conventional radioisotopes production with industrial mid-energy cyclotron

First experience on producing gallium-68 with liquid target at HUS Medical Imaging Center using a Cyclone KIUBE 180 cyclotron

Securing Gallium-68 availability with liquid target production on mid-energy cyclotrons: Users' experience

Ga68Ga-68

To produce Ga-68,we recommend this production route:

Cyclone:

Target:

Chemistry:

Cyclone:

Target:

Chemistry:

Cyclone:

Target:

Chemistry:

Target:

Chemistry:

Scientific publications

Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population

Automated synthesis of therapeutic activities of 177Lu and 131I radiopharmaceuticals and 68Ga PET agents in a hospital radiopharmacy.

Automated [68Ga]DOTA-NOC Production Using a Commercial Synthesizer

Simplified Automation of the GMP production of 68Ga-labelled peptides

Fully automated synthesis of 68Ga-labelled peptides using the IBA Synthera® and Synthera® Extension modules

Combining commercial production of multi-products in a GMP environment with Clinical & R&D activities

GMP Production of Gallium-68 from a Cyclotron Using Liquid Targets: Regulatory Aspects

Automated Purification of Radiometals Produced by Liquid Targets

Combining multi-product commercial production in a GMP environment with Clinical & R&D activities

Cyclotron production of Ga‐68 for human use from liquid targets: From theory to practice

GMP Production of Gallium-68 from a Cyclotron Using Liquid Targets: Regulatory Aspects

Production of copper-64 and gallium-68 with a medical cyclotron using liquid targets

Fast and cost-effective cyclotron production of 61Cu using a natZn liquid target: an opportunity for radiopharmaceutical production and R&D

Optimized non-conventional radioisotopes production with industrial mid-energy cyclotron

First experience on producing gallium-68 with liquid target at HUS Medical Imaging Center using a Cyclone KIUBE 180 cyclotron

Securing Gallium-68 availability with liquid target production on mid-energy cyclotrons: Users' experience

To produce Ga-68,
we recommend this production route:

Automated synthesis of therapeutic activities of 177Lu and 131I radiopharmaceuticals and ⁶⁸Ga PET agents in a hospital radiopharmacy.

Automated [⁶⁸Ga]DOTA-NOC Production Using a Commercial Synthesizer

Fully automated synthesis of 68Ga-labelled peptides using the IBA Synthera^® and Synthera^® Extension modules